|
Ruff helps lead a team of seasoned pharmaceutical scientists and technicians at Metrics. Prior to joining Metrics in 1997, Ruff had 11 years of experience as a formulation scientist with a concentration on solid dosage forms and clinical trial manufacture. Ruff holds four patents and one patent pending for innovative drug stabilization techniques and coating technology. Commercial pharmaceutical products he has formulated include Wellbutrin SR®/Zyban®, Lamictal®, and Agenerase®. Ruff holds bachelor’s of science degrees in pharmacy and zoology from the University of Texas. | 